CORO1C: A Potential Drug Target and Biomarker for Coronavirus 19

Target Name: CORO1C

NCBI ID: G23603

CORO1C

CORO1C: A Potential Drug Target and Biomarker for Coronavirus 19

The COVID-19 pandemic has resulted in a global loss of lives, economic instability, and social disruption. The virus has been declared a global pandemic by the World Health Organization (WHO) and has affected millions of people worldwide. The search for a cure and a treatment has become a top priority, and the development of new drugs and targets is crucial in this effort. One promising candidate for a drug target and biomarker for COVID-19 is the protein CORO1C.

CORO1C: The Potential Drug Target

CORO1C, or Corpus callosum protein 1C, is a protein that is expressed in various tissues and organs, including the brain, lungs, heart, and liver. It is a member of the Integrin伪6 chain and is involved in cell-cell adhesion, migration, and invasion. The COVID-19 pandemic has highlighted the importance of this protein as a potential drug target.

The beauty of CORO1C lies in its unique structure and its ability to interact with other proteins. Its unique amino acid sequence makes it an attractive target for small molecules, making it a promising candidate for anti-inflammatory and anti-inflammatory drugs. TheCorpus callosum is a protein that plays a crucial role in the development and maintenance of tissue repair following injury or inflammation. It is also involved in the regulation of cell adhesion and migration, which are critical processes in the development and progression of cancer.

CORO1C as a Biomarker

The availability of a reliable and valid biomarker for COVID-19 has been a significant challenge. The current gold standard for diagnosing COVID-19 is PCR, which is time-consuming and requires laboratory resources. As a result, there is an urgent need for a more efficient and less expensive biomarker.

CORO1C could provide a new and more accurate biomarker for COVID-19. The protein is expressed in various tissues and organs and can be used as a protein biomarker in diagnostic tests. Its unique structure and the ease of its production make it an attractive candidate for use as a biomarker.

CORO1C as a Potential Therapeutic

The development of new drugs is a critical aspect of the COVID-19 response. The search for a treatment has led to the use of existing drugs and the development of new ones. The use of CORO1C as a drug target could lead to the development of new anti-inflammatory and anti-cancer drugs.

One approach to developing a new drug targeting CORO1C is to use small molecules to modulate its activity. The unique structure of CORO1C makes it an attractive target for small molecules. The use of virtual screening and high-throughput screening techniques can be used to identify potential small molecules that interact with CORO1C.

CORO1C as a Potential Biomarker and Drug Target

The COVID-19 pandemic has resulted in a global loss of lives, economic instability, and social disruption. The development of new drugs and targets is crucial in this effort. The protein CORO1C is a promising candidate for a drug target and biomarker for COVID-19. Its unique structure and the ease of its production make it an attractive candidate for use in diagnostic tests and as a drug target.

In conclusion, the protein CORO1C is a promising candidate for a drug target and biomarker for COVID-19. Its unique structure and the ease of its production make it an attractive candidate for use in diagnostic tests and as a new drug. Further research is needed to

Protein Name: Coronin 1C

Functions: Plays a role in directed cell migration by regulating the activation and subcellular location of RAC1 (PubMed:25074804, PubMed:25925950). Increases the presence of activated RAC1 at the leading edge of migrating cells (PubMed:25074804, PubMed:25925950). Required for normal organization of the cytoskeleton, including the actin cytoskeleton, microtubules and the vimentin intermediate filaments (By similarity). Plays a role in endoplasmic reticulum-associated endosome fission: localizes to endosome membrane tubules and promotes recruitment of TMCC1, leading to recruitment of the endoplasmic reticulum to endosome tubules for fission (PubMed:30220460). Endosome membrane fission of early and late endosomes is essential to separate regions destined for lysosomal degradation from carriers to be recycled to the plasma membrane (PubMed:30220460). Required for normal cell proliferation, cell migration, and normal formation of lamellipodia (By similarity). Required for normal distribution of mitochondria within cells (By similarity)

The "CORO1C Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about CORO1C comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets